[Form 4] NVR INC Insider Trading Activity
Insider option grant reported for NVR, Inc. Director George Oliver received an award of 338 stock options on 10/01/2025 under the NVR, Inc. 2018 Equity Incentive Plan. The options are exercisable for 338 shares of common stock and are reported as held directly by the reporting person. The grant vests in four equal 25% installments on 12/31/27, 12/31/28, 12/31/29 and 12/31/30. The reported conversion/exercise price is listed as $8,034.66 and the options have an exercisable/expiration schedule noted with an expiration date of 09/30/2035. The filing was submitted by an attorney-in-fact on behalf of the reporting person.
- Director received equity-based compensation: 338 stock options granted under the NVR, Inc. 2018 Equity Incentive Plan.
- Clear multi-year vesting schedule: Options vest 25% on each of 12/31/27, 12/31/28, 12/31/29 and 12/31/30, supporting retention.
- None.
Insights
TL;DR: A director received a modest equity grant with multi-year vesting, typical for retention alignment.
The Form 4 discloses a director-level grant of 338 stock options under the companys 2018 Equity Incentive Plan. The vesting schedule is specified clearly in the filing: four equal tranches at year-ends 2027 through 2030. The grant size, as reported, appears routine for director compensation plans and is structured to retain service through 2030. The filing shows direct ownership of the underlying 338 shares post-grant and an expiration date in 2035. No other transactions or dispositions are reported.
TL;DR: Compensation award aligns director incentives with long-term performance via time-based vesting to 2030.
The disclosure specifies the awards terms: 338 options granted on 10/01/2025 with vesting in 25% increments on each of four year-ends and an indicated expiration of 09/30/2035. Such time-based vesting is a standard retention mechanism and does not, by itself, indicate unusual dilution or immediate cash impact. The Form 4 was filed by an attorney-in-fact, which is properly noted. The conversion/exercise price is reported in the form and should be cross-checked with company equity plan documents for interpretation of per-share economics.